Skip to main content

Closed

DRUG: Bright Minds Biosciences Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin0.0%

ROIC-10.2%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-2438.6×

Current ratio81.48×

Bright Minds Biosciences Inc.

DRUGNASDAQ·USD·Closed

Bright Minds Biosciences Inc.

DRUGNASDAQ·USD·Closed

$73.26

−1.84%

$73.26

−$1.37 (1.84%)

52W Range

45thpctl

Volume

0.67×avg

Mkt Cap

717.01MUSD

P/E

-30.4TTM

Div Yield

–ann

52W Range

45thpctl

Volume

0.67×avg

Market Cap

717.01MUSD

P/E Ratio

-30.4TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings